Pope Francis’ overall clinical condition is “improving slightly” and his heart is working well as he battles pneumonia, the ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placeboSPN-820 was well-tolerated ...

Confirmatory Phase 3 Trial Designed to Support Commercialization of Multikine for Head and Neck Cancer Treatment. Full enrollment expected by Q2 2026 with plans to seek early appr ...

Combination Achieved a 67% of Overall Response Rate, More than Double that of Zanubrutinib Alone; 83% Disease Control Rate in Difficult-to-Treat Non-GCB DLBCL (ABC DLBCL) Patients - - Median Overall ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

Layoffs, funding freezes, and executive orders spark outcry among federal researchers and university partners, fearing that ...